What the research found
A 2023 pooled analysis of nearly 8 million people across 79 countries found that roughly half the global population has a serum 25-hydroxyvitamin D below 20 ng/mL, and about three-quarters fall below 30 ng/mL. In the United States specifically, approximately 40% meet clinical deficiency criteria. The shortfall is starkest in older adults and Black Americans, where rates approach 60%.
When researchers measured populations living traditional lifestyles in East Africa—outdoor-based, with minimal sun avoidance—baseline vitamin D levels averaged around 46 ng/mL with no supplementation. This contrasts sharply with modern Western populations averaging roughly 25 ng/mL, suggesting contemporary indoor living, clothing norms, sunscreen use, and dietary shifts have created a systematic halving of ancestral vitamin D exposure.
A 2025 analysis of U.S. poison control calls noted a 78% rise in vitamin D-related reports between 2012 and 2022. However, the source emphasizes this reflects call volume, not clinical severity. Earlier detailed analysis of over 25,000 vitamin D exposure reports found zero deaths, major adverse effects in 0.02%, and declining proportions requiring medical evaluation even as call numbers increased—suggesting more calls reflected parental worry or dosing questions rather than actual toxicity.
Why it matters for you
If you're tracking biomarkers on MyKine, vitamin D is probably on your list. A level of 28–30 ng/mL—common among users feeling otherwise "healthy"—falls into the lower half of modern distribution but well below the ancestral baseline and below what most research associates with optimal immune function, bone density, mood stability, and recovery from training. Fatigue, poor sleep quality, joint aches, and sluggish adaptation to training stress are often attributed to training load or sleep when vitamin D insufficiency is actually present.
The practical takeaway: deficiency is now statistically normal in modern populations, which makes it easy to dismiss as non-problematic. If you're experiencing low energy, poor wound healing, mood dysregulation, or hair loss alongside a 25–35 ng/mL reading, raising that number toward 40–50 ng/mL (the ancestral range) is a lower-risk intervention than waiting for symptoms to worsen. The toxicity risk cited in recent headlines relates to call volume, not clinical harm; the same analysis showed that actual severe vitamin D toxicity remains extremely rare.
Caveats
- Observational and cross-sectional: Comparisons between hunter-gatherer populations and modern Western cohorts don't prove causation of current symptoms, only association with sun exposure patterns.
- Ancestral baseline may not equal optimal modern level: Traditional populations also had different diets, activity patterns, and genetic backgrounds; "46 ng/mL" is a reference point, not a prescription.
- Poison control data conflation: Absolute call numbers rising doesn't mean toxicity incidence rose proportionally—this reflects increased supplement use and reporting, not necessarily increased harm.
- No new mechanistic studies presented: The briefing relies on epidemiology and historical patterns, not recent RCTs on vitamin D supplementation.